Skip to main content
Livermore
Livermore
ZHEN

Bruce & Co., Inc.

SEC CIK
0001358331
Latest filing
Aug 14, 2026

The latest 13F from Bruce & Co., Inc. covers Q2 2026 (filed Aug 14, 2026): 41 long positions worth $369.5M. The top 10 holdings make up 60.6% of the portfolio, and the largest is AbbVie Inc. (ABBV) at 8.2%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
4
Est. +$4.89M
Reduced
18
Est. −$12.0M
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. ABBVAbbVie Inc.
    8.2%$30.4MHistory
  2. ALLAllstate Corp
    7.9%$29.1MHistory
  3. AERAerCap Holdings N.V.
    7.3%$27.0MHistory
  4. FPL Group Inc302571104
    7.0%$25.8M
  5. MRKMerck & Co., Inc.
    6.6%$24.5MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. SUPNSupernus Pharmaceuticals, Inc.
    +$2.33MAddedHistory
  2. BBNXBeta Bionics, Inc.
    +$1.80MAddedHistory
  3. FATEFate Therapeutics Inc
    +$540.0KAddedHistory
  4. AERAerCap Holdings N.V.
    +$218.7KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. BBNXBeta Bionics, Inc.
    +1.25 pp1.6% → 2.8%History
  2. FATEFate Therapeutics Inc
    +0.45 pp0.3% → 0.7%History
  3. SUPNSupernus Pharmaceuticals, Inc.
    +0.41 pp1.5% → 1.9%History
  4. AERAerCap Holdings N.V.
    +0.10 pp7.2% → 7.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. VICRVicor Corp
    −$6.46MReducedHistory
  2. UHAL.BU-Haul Holding Co
    −$2.02MReducedHistory
  3. ALLAllstate Corp
    −$713.8KReducedHistory
  4. AAPLApple Inc.
    −$578.7KReducedHistory
  5. FPL Group Inc302571104
    −$526.6KReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TAT&T Inc.
    −1.43 pp4.3% → 2.9%History
  2. FPL Group Inc302571104
    −0.99 pp8.0% → 7.0%
  3. ABTAbbott Laboratories
    −0.58 pp3.3% → 2.8%History
  4. DUKDuke Energy CORP
    −0.50 pp5.5% → 5.0%History
  5. PFEPfizer Inc
    −0.44 pp2.2% → 1.7%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$369.5M
+$19.8M (+5.7%) vs. prior quarter
Positions
41
0 vs. prior quarter
Top 10 concentration
60.6%
Top 10 as share of value
Turnover
1.4%
Q2 2026, one quarter
Average holding period
17.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $533.8M (Q1 2021)

Q1 2021: $533.8MQ2 2021: $523.6MQ3 2021: $470.7MQ4 2021: $500.1MQ1 2022: $489.1MQ2 2022: $425.1MQ3 2022: $363.9MQ4 2022: $387.9MQ1 2023: $366.9MQ2 2023: $356.5MQ3 2023: $293.4MQ4 2023: $286.6MQ1 2024: $301.5MQ2 2024: $304.0MQ3 2024: $343.6MQ4 2024: $311.4MQ1 2025: $311.8MQ2 2025: $308.5MQ3 2025: $322.9MQ4 2025: $322.5MQ1 2026: $349.7MQ2 2026: $369.5M
Q1 2021Q2 2026
13F filings of Bruce & Co., Inc. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202641$369.5MABBVALLAERvs. Q1 2026SEC
Q1 2026May 14, 202641$349.7MFPL Group IncABBVALLvs. Q4 2025SEC
Q4 2025Feb 13, 202639$322.5MABBVAERALLvs. Q3 2025SEC
Q3 2025Nov 13, 202539$322.9MABBVALLFPL Group Incvs. Q2 2025SEC
Q2 2025Aug 14, 202541$308.5MALLUHAL.BABBVvs. Q1 2025SEC
Q1 2025May 14, 202542$311.8MUHAL.BABBVALLvs. Q4 2024SEC
Q4 2024Feb 11, 202541$311.4MUHAL.BALLABBVvs. Q3 2024SEC
Q3 2024Nov 14, 202441$343.6MUHAL.BABBVFPL Group Incvs. Q2 2024SEC
Q2 2024Aug 9, 202440$304.0MUHAL.BMRKABBVvs. Q1 2024SEC
Q1 2024May 13, 202439$301.5MUHAL.BMRKABBVvs. Q4 2023SEC
Q4 2023Feb 12, 202437$286.6MUHAL.BMRKABBVvs. Q3 2023SEC
Q3 2023Nov 13, 202338$293.4MUHAL.BABBVMRKvs. Q2 2023SEC
Q2 2023Aug 8, 202337$356.5MMRKUHAL.BABBVvs. Q1 2023SEC
Q1 2023May 12, 202337$366.9MUHAL.BMRKABBVvs. Q4 2022SEC
Q4 2022Feb 15, 202337$387.9MUHAL.BMRKABBVvs. Q3 2022SEC
Q3 2022Nov 15, 202234$363.9MUHALABBVALLvs. Q2 2022SEC
Q2 2022Aug 9, 202233$425.1MUHALFPL Group IncABBVvs. Q1 2022SEC
Q1 2022May 11, 202232$489.1MUHALFPL Group IncABBVvs. Q4 2021SEC
Q4 2021Feb 16, 202231$500.1MUHALFPL Group IncABBVvs. Q3 2021SEC
Q3 2021Nov 12, 202131$470.7MUHALFPL Group IncBausch Healthvs. Q2 2021SEC
Q2 2021Aug 16, 202131$523.6MUHALALLBausch Healthvs. Q1 2021SEC
Q1 2021May 17, 202135$533.8MUHALBausch HealthFPL Group Inc–SEC